文献速递妇科

联合症状指数、CA125与HE4(三联筛查)在盆腔包块女性中检测卵巢癌

Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
PubMed 文献 · Gynecol Oncol · 2017-08-30

这项前瞻性研究纳入218例因盆腔包块转诊妇科肿瘤门诊行手术评估的女性,术前完成症状指数并检测血清CA125与HE4,三联筛查阳性定义为3项中至少2项异常。排除交界性和转移性癌后,三联筛查灵敏度79%、特异度91%、PPV 83%、NPV 89%,特异度和PPV高于单用CA125,灵敏度和NPV相似。

要点

  • 三联筛查(症状指数、CA125、HE4中至少2项异常)在盆腔包块女性中预测卵巢癌:灵敏度79%、特异度91%。
  • 单用CA125的灵敏度79%、特异度76%、PPV 63%、NPV 87%。
  • 仅要求3项中1项异常时灵敏度升至97%,但特异度降至50%。

核心结论

  • 使用症状指数、CA125和HE4的算法在盆腔包块女性中预测癌症具有较好的性能统计。
  • 三联筛查预测卵巢癌的特异度和PPV高于单用CA125,但灵敏度和NPV相似。

研究设计与样本

  • 前瞻性研究,纳入因盆腔包块转诊妇科肿瘤门诊行手术评估的女性。
  • 术前完成症状指数并采集血清标志物,结果与病理对照。
  • 共218例患者入组。

主要发现

  • 66例(30%)为卵巢或输卵管癌(97%为上皮性),124例(57%)为良性包块,17例(8%)为交界性肿瘤,11例(5%)为转移性疾病。
  • 卵巢癌患者中症状指数、CA125和HE4阳性率分别为87.9%、74.2%和60.6%。
  • 112例症状指数阳性女性中,58例(52%)为卵巢癌,75例(67%)为非良性包块。
  • 排除交界性和转移性癌后,三联筛查灵敏度79%、特异度91%、PPV 83%、NPV 89%。
  • 单用CA125的灵敏度、特异度、PPV和NPV分别为79%、76%、63%和87%。

关键数值与推荐

  • 三联筛查阳性定义为至少2项异常:症状指数阳性、CA125≥35U/mL、HE4≥140pmol/L。
  • 仅要求3项中1项异常时,灵敏度97%,特异度降至50%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess a simple algorithm of CA125, HE4 and Symptom Index to predict ovarian cancer in women with a pelvic mass. METHODS: This was a prospective study of women referred to a gynecologic oncology clinic for surgical evaluation of a pelvic mass. Preoperatively, women completed a SI and had serum markers drawn. Results were correlated with pathology. A triple screen was considered positive if at least 2 of the 3 markers were abnormal (positive SI, CA125≥35U/mL, HE4≥140pmol/L). RESULTS: 218 patients enrolled in the study. 66 patients (30%) had ovarian or fallopian tube cancer (97% epithelial), 124 (57%) had benign masses, 17 (8%) had borderline tumors, and 11 (5%) had metastatic disease. The SI, CA125 and HE4 were positive in 87.9%, 74.2% and 60.6% of ovarian cancer patients, respectively. Of the 112 women with a positive SI 58 (52%) had ovarian cancer and 75 (67%) had non-benign masses. Excluding borderline and metastatic cancers the sensitivity of the triple screen was 79%; specificity 91%, PPV 83% and NPV 89%. CA125 alone had a sensitivity, specificity, PPV and NPV of 79%, 76%, 63% and 87% respectively. Requiring only one of the three tests to be abnormal resulted in a sensitivity of 97% but specificity dropped to 50%. CONCLUSIONS: An algorithm using SI, CA125 and HE4 has good performance statistics for predicting cancer in women with pelvic masses. The triple screen has higher specificity and PPV than CA125 alone but similar sensitivity and NPV for predicting ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Goff BA, Agnew K, Neradilek MB, et al. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecol Oncol. 2017. PMID: 28860006. doi:10.1016/j.ygyno.2017.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。